Pfizer is betting big on cancer drugs to turn business around after Covid decline – here’s what to know

The pharmaceutical giant has been trying to shore up investor sentiment after its shares fell more than 40% in 2023.

Previous post Saudi oil giant Aramco posts 25% fall in full-year profit
Next post Earnings this week will look at the shoppers hit hardest by inflation